We are live on ! Find out more
RDHL

Redhill Biopharma
RDHL

37 hedge funds and large institutions have $56.8M invested in Redhill Biopharma in 2019 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 5 increasing their positions, 8 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

133% more first-time investments, than exits

New positions opened: 7 | Existing positions closed: 3

70% more call options, than puts

Call options by funds: $303K | Put options by funds: $178K

36% more capital invested

Capital invested by funds: $41.7M → $56.8M (+$15.1M)

9% more funds holding

Funds holding: 34 → 37 (+3)

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

0% less ownership

Funds ownership: 0% → 0% (-0%)

38% less repeat investments, than reductions

Existing positions increased: 5 | Existing positions reduced: 8

Holders
37
Holders Change
+3
Holders Change %
+8.82%
% of All Funds
0.81%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.04%
New
7
Increased
5
Reduced
8
Closed
3
Calls
$303K
Puts
$178K
Net Calls
+$125K
Net Calls Change
+$27K

Top Buyers

Rank Fund Capital Flow
1
UOC
UBS O'Connor
Illinois
+$604K
2
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$546K
3
Boston Partners
Boston Partners
Massachusetts
+$197K
4
IIM
Ironwood Investment Management
Massachusetts
+$131K
5
CAM
Claret Asset Management
Quebec, Canada
+$94.6K

Top Sellers

Rank Fund Capital Flow
1
6CM
683 Capital Management
New York
-$1.59M
2
Jane Street
Jane Street
New York
-$384K
3
Millennium Management
Millennium Management
New York
-$357K
4
Morgan Stanley
Morgan Stanley
New York
-$335K
5
II
Ibex Investors
Colorado
-$72.8K
Name Holding Trade Value Shares
Change 		Change in
Stake
FDCDDQ
26
Federation des caisses Desjardins du Quebec
Quebec, Canada
$58.9K -$43.7K -6 -43%
Bank of America
27
Bank of America
North Carolina
$21K – – –
Royal Bank of Canada
28
Royal Bank of Canada
Ontario, Canada
$21K – – –
UBS Group
29
UBS Group
Switzerland
$17K -$7.28K -1 -33%
Wells Fargo
30
Wells Fargo
California
$17K +$7.28K +1 +100%
LTFS
31
Ladenburg Thalmann Financial Services
Florida
$16K – – –
FANJ
32
Financial Architects (New Jersey)
New Jersey
$14K – – –
CG
33
Cutler Group
California
$9K +$7.28K +1 New
TRCT
34
Tower Research Capital (TRC)
New York
$8K – – –
Group One Trading
35
Group One Trading
Illinois
$8K +$7.28K +1 New
PVH
36
Psagot Value Holdings
Israel
$4K – – –
SPIA
37
Steward Partners Investment Advisory
New York
$3K – – –
IA
38
IFP Advisors
Florida
$2K – – –
Jane Street
39
Jane Street
New York
– -$384K -59 Closed
VF
40
Virtu Financial
New York
– -$72K -11 Closed
Commonwealth Equity Services
41
Commonwealth Equity Services
Massachusetts
– -$65K -10 Closed
1
2

RDHL Hedge Fund Activity: Q3 2019 in Review

37 of the 4,560 institutional investors tracked by Wall St. Rank reported a position in Redhill Biopharma (RDHL) for Q3 2019, worth a combined $56.8M — up 36% from $41.7M a quarter earlier.

Buyers outnumbered sellers: 7 funds opened new RDHL positions and 3 closed out — a net gain of 4 holders — while 5 added to existing stakes and 8 trimmed.

The largest buyer was UBS O'Connor, opening a new position worth an estimated $604K. The largest seller was 683 Capital Management, cutting an estimated $1.59M.

  • 37 institutional investors held Redhill Biopharma (RDHL) as of Q3 2019, up from 34 in Q2 2019.
  • Funds reported $56.8M of Redhill Biopharma stock for Q3 2019, up 36% quarter-over-quarter.
  • 7 funds opened new Redhill Biopharma positions in Q3 2019 and 3 closed out, a net change of +4 holders.
  • The largest Redhill Biopharma buyer in Q3 2019 was UBS O'Connor, an estimated $604K added.
  • The largest Redhill Biopharma seller in Q3 2019 was 683 Capital Management, an estimated $1.59M sold.

Based on aggregated 13F filings for Q3 2019.